The role of antirheumatics in patients with COVID-19.
Nissen CB, Sciascia S, de Andrade D, Atsumi T, Bruce IN, Cron RQ, Hendricks O, Roccatello D, Stach K, Trunfio M, Vinet É, Schreiber K.
Nissen CB, et al.
Lancet Rheumatol. 2021 Jun;3(6):e447-e459. doi: 10.1016/S2665-9913(21)00062-X. Epub 2021 Mar 30.
Lancet Rheumatol. 2021.
PMID: 33817665
Free PMC article.
Review.
The COVID-19 pandemic has resulted in more than 2 million deaths globally. ...Therefore, many immune modulators and immunosuppressive drugs, which are widely used in rheumatological practice, have been proposed as treatments for patients with moderate or seve …
The COVID-19 pandemic has resulted in more than 2 million deaths globally. ...Therefore, many immune modulators and imm …